Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions

Breast Cancer Research and Treatment

Volumn 45, Issue 1, 1997, Pages 39-46

  Stomper, Paul C ^a,c   Winston, Janet S ^a   Herman, Steven ^a   Klippenstein, Donald L ^a   Arredondo, Mark A ^a   Blumenson, Leslie E ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Breast MRI; Gadolinium enhancement

Indexed keywords

BLOOD CLOTTING FACTOR 8; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST LESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030876719     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005897227030     Document Type: Article

References (30)

1. Weidner N, Folkman J: Tumoral vascularity as a prognostic factor in cancer. In: De Vita VT, Hellman S, Rosenberg SA (eds) Important Advances in Oncology 1996. Lippincott-Raven Publishers, Philadelphia, 1996. pp 167-190
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992
3. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator of primary breast carcinoma. Int J Cancer 55: 371-374, 1993
4. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994
5. Obermair A, Czerwenka K, Kurz C et al.: Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: preliminary results. Onkologie 17:44-49, 1994
6. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumor vascularity us a prognostic factor in lymph nude negative invasive breast cancer. Eur J Cancer 29A: 1141-1145, 1993
7. Miliaras D, Kamas A, Kalekou H: Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology 26: 165-169, 1995
8. Axelsson K, Ljung BME, Moore DH, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH: Tumor angiogenesis as a prognostic assay for invasive ductal carcinoma. J Natl Cancer Inst 87: 997-1008, 1995
9. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995
10. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13: 765-782, 1995
11. Weinreb JC, Newstead G: MR imaging of the breast. Radiology 196: 593-610, 1995
12. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187:493-501, 1993
13. Heywang-Koebrunner SH: Diagnosis of breast cancer with MR - review after 1250 patient examinations. Electromedica 61: 43-52, 1993
14. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT: Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174: 491-494, 1990
15. Rubens D, Totterman S, Chacko AK, Kothari K, Logan-Young W, Szumowski J, Simon JH, Zachariah E: Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. Am J Roentgenol 157: 267-270, 1991
16. Orel S, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, Torosian MH, Rosato EF: Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196: 115-122, 1995
17. Flickinger FW, Allison JD, Sherry RM, Wright JC: Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Res Imaging 11: 617-620, 1993
18. Orel S, Schnall MD, LiVolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologic-pathologic correlations. Radiology 190: 485-493, 1994
19. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ: Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 196: 143-152, 1995
20. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE: Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197: 387-395, 1995
21. Frouge C, Guinebretière JM, Contesso G, Di Paola R, Bléry M: Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Investigative Radiology 29(12): 1043-1049, 1994
22. Gilles R, Zafrani B, Guinebretière JM, Meunier M, Lucidarme O, Tardivon AA, Rochard F, Vanel D, Neuenschwander S, Arriagada R: Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196: 415-419, 1995
23. Hulka CA, Smith BL, Sgroi DC, Tan L, Edmister WB, Semple JP, Campbell T, Kopans DB, Brady TJ, Weisskoff RM: Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 197: 33-38, 1995
24. Fleiss JL: Statistical Methods for Rates and Proportions. 2nd edition. John Wiley & Sons, New York, 1981, pp 20-27
25. Jain RK: Barriers to drug delivery in solid tumors. Scientific American 271(1): 58-65, 1994
26. Jain RK: 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors. Ann Biomed Engin 24:457-473, 1996
27. Guidi AJ, Fischer L, Harris JR, Schnitt SJ: Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86: 614-619, 1994
28. van Dijke CF, Brasch RC, Roberts TPL, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, Schwickert HC: Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198: 813-818, 1996
29. Schwickert H, Stiskal M, Roberts T, van Dijke CF, Mann J, Muhler A, Shames DM, Demsar F, Disston A, Brasch RC: Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of pre-irradiation on the tumor delivery of chemotherapy. Radiology 198: 893-898, 1996
30. Cohen FM, Kuwatsuru R, Shames DM, Neuder M, Mann JS, Vexler V, Rosenau W, Brasch RC: Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest Radiol 29: 970-977, 1994